205 related articles for article (PubMed ID: 9247297)
1. Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy.
Funatomi H; Itakura J; Ishiwata T; Pastan I; Thompson SA; Johnson GR; Korc M
Int J Cancer; 1997 Jul; 72(3):512-7. PubMed ID: 9247297
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic effects of TGF-alpha-Pseudomonas exotoxin A fusion protein in human pancreatic carcinoma cells.
Baldwin RL; Kobrin MS; Tran T; Pastan I; Korc M
Pancreas; 1996 Jul; 13(1):16-21. PubMed ID: 8783329
[TBL] [Abstract][Full Text] [Related]
3. Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis.
Damstrup L; Kuwada SK; Dempsey PJ; Brown CL; Hawkey CJ; Poulsen HS; Wiley HS; Coffey RJ
Br J Cancer; 1999 Jun; 80(7):1012-9. PubMed ID: 10362109
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells.
Sehgal I; Bailey J; Hitzemann K; Pittelkow MR; Maihle NJ
Mol Biol Cell; 1994 Mar; 5(3):339-47. PubMed ID: 8049525
[TBL] [Abstract][Full Text] [Related]
5. Amphiregulin anti-sense oligodeoxynucleotides inhibit growth and transformation of a human colon carcinoma cell line.
Normanno N; Selvam MP; Bianco C; Damiano V; de Angelis E; Grassi M; Magliulo G; Tortora G; Salomon DS; Ciardiello F
Int J Cancer; 1995 Sep; 62(6):762-6. PubMed ID: 7558427
[TBL] [Abstract][Full Text] [Related]
6. Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon.
Johnson GR; Saeki T; Gordon AW; Shoyab M; Salomon DS; Stromberg K
J Cell Biol; 1992 Aug; 118(3):741-51. PubMed ID: 1639855
[TBL] [Abstract][Full Text] [Related]
7. Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells.
Normanno N; Selvam MP; Qi CF; Saeki T; Johnson G; Kim N; Ciardiello F; Shoyab M; Plowman G; Brandt R
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2790-4. PubMed ID: 7908443
[TBL] [Abstract][Full Text] [Related]
8. Colorectum cell-derived growth factor (CRDGF) is homologous to amphiregulin, a member of the epidermal growth factor family.
Culouscou JM; Remacle-Bonnet M; Carlton GW; Plowman GD; Shoyab M
Growth Factors; 1992; 7(3):195-205. PubMed ID: 1333777
[TBL] [Abstract][Full Text] [Related]
9. Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells.
De Luca A; Selvam MP; Sandomenico C; Pepe S; Bianco AR; Ciardiello F; Salomon DS; Normanno N
Int J Cancer; 1997 Oct; 73(2):277-82. PubMed ID: 9335455
[TBL] [Abstract][Full Text] [Related]
10. Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cells.
Wagner M; Weber CK; Bressau F; Greten FR; Stagge V; Ebert M; Leach SD; Adler G; Schmid RM
Gastroenterology; 2002 Jun; 122(7):1898-912. PubMed ID: 12055597
[TBL] [Abstract][Full Text] [Related]
11. EGF-related antisense oligonucleotides inhibit the proliferation of human ovarian carcinoma cells.
Casamassimi A; De Luca A; Agrawal S; Stromberg K; Salomon DS; Normanno N
Ann Oncol; 2000 Mar; 11(3):319-25. PubMed ID: 10811499
[TBL] [Abstract][Full Text] [Related]
12. The heparin-binding domain of amphiregulin necessitates the precursor pro-region for growth factor secretion.
Thorne BA; Plowman GD
Mol Cell Biol; 1994 Mar; 14(3):1635-46. PubMed ID: 8114701
[TBL] [Abstract][Full Text] [Related]
13. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.
Riese DJ; Kim ED; Elenius K; Buckley S; Klagsbrun M; Plowman GD; Stern DF
J Biol Chem; 1996 Aug; 271(33):20047-52. PubMed ID: 8702723
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical studies on EGF family growth factors in normal and ulcerated human gastric mucosa.
Abe S; Sasano H; Katoh K; Ohara S; Arikawa T; Noguchi T; Asaki S; Yasui W; Tahara E; Nagura H; Toyota T
Dig Dis Sci; 1997 Jun; 42(6):1199-209. PubMed ID: 9201085
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of epidermal growth factor-related proteins in human colorectal tumors.
Ciardiello F; Kim N; Saeki T; Dono R; Persico MG; Plowman GD; Garrigues J; Radke S; Todaro GJ; Salomon DS
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7792-6. PubMed ID: 1715580
[TBL] [Abstract][Full Text] [Related]
16. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling.
Wong L; Deb TB; Thompson SA; Wells A; Johnson GR
J Biol Chem; 1999 Mar; 274(13):8900-9. PubMed ID: 10085134
[TBL] [Abstract][Full Text] [Related]
17. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development.
Luetteke NC; Qiu TH; Fenton SE; Troyer KL; Riedel RF; Chang A; Lee DC
Development; 1999 Jun; 126(12):2739-50. PubMed ID: 10331984
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells.
Kondapaka SB; Fridman R; Reddy KB
Int J Cancer; 1997 Mar; 70(6):722-6. PubMed ID: 9096655
[TBL] [Abstract][Full Text] [Related]
19. Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas.
Mishima K; Higashiyama S; Asai A; Yamaoka K; Nagashima Y; Taniguchi N; Kitanaka C; Kirino T; Kuchino Y
Acta Neuropathol; 1998 Oct; 96(4):322-8. PubMed ID: 9796995
[TBL] [Abstract][Full Text] [Related]
20. Selective abrogation of the proinvasive activity of the trefoil peptides pS2 and spasmolytic polypeptide by disruption of the EGF receptor signaling pathways in kidney and colonic cancer cells.
Rodrigues S; Attoub S; Nguyen QD; Bruyneel E; Rodrigue CM; Westley BR; May FE; Thim L; Mareel M; Emami S; Gespach C
Oncogene; 2003 Jul; 22(29):4488-97. PubMed ID: 12881705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
